Articles related to BIRTH DEFECTS

First-trimester benzodiazepine exposure was not associated with a meaningful increase in major congenital malformations in a large US cohort study, although findings related to coexposure with other psychoactive medications remained inconsistent and require further investigation.

The court held that damages can extend to the long-term care of the child with special needs.

Vitamin B12 deficiency manifests in four critical ways: anemia, nerve damage, birth defects, and DNA damage. Recognizing these key symptoms and understanding their underlying mechanisms is essential for timely diagnosis and effective treatment, potentially preventing severe long-term health consequences.

This case emphasizes the crucial role of continuous fetal monitoring and timely intervention during labor, particularly when signs of distress are present.

ART-conceived singleton infants had an elevated risk for major genitourinary abnormalities. This risk remained unchanged even when accounting for parental infertility.

Although research exists on the impact of CNS stimulants used in pregnancy, only a few small studies have looked at atomoxetine and pregnancy outcomes. This large cohort study of 4.2 million pregnancies ending in live births in northern Europe and the US reviewed nearly 1,000 pregnancies exposed to atomoxetine in the first trimester. Compared with non-exposed pregnancies, there was no observed increase in major congenital abnormalities with atomoxetine use in the first trimester.